New drug review processes would be accelerated and completed in 120 days in response to a US plan to raise pharmaceutical tariffs, the Ministry of Health and Welfare said yesterday.
Food and Drug Administration (FDA) Deputy Director-General Wang Der-yuan (王德原) yesterday told a news conference that measures have been taken to optimize new medicine review processes and help pharmaceutical companies obtain drug permit licenses as soon as possible.
Such processes normally take about 360 days to complete, if the new medicine is a new chemical entity (NCE) — a drug with new chemicals as principal components — or a drug made from biological sources, also known as biologics.
Photo: AP
However, NCEs or biologics considered important for pediatric treatments and serious diseases, as well as breakthrough therapies can have their review prioritized, with the process shortened to 240 days, he said.
If an NCE or a biologic has been approved in two of the US, the EU or Japan, it is qualified for a “type 1 express review” and can have its review completed as fast as in 180 days, Wang said.
If it has been approved in the three areas with identical data on chemistry, manufacturing and controls, it is qualified for a “type 2 express review” and its review process could be completed in 120 days, he added.
The ministry would also continue to encourage pharmaceutical companies to diversify sources of bulk drugs or active pharmaceutical ingredients so that they would not rely on a single supplier, he said.
China and India are the two major sources of bulk drugs used in Taiwan’s pharmaceutical industry, he said.
The FDA has requested pharmaceutical companies to evaluate whether they should find more bulk drug sources, Wang said, adding that the agency would prioritize the review of new medicines relying on a single source.
Pharmaceutical companies should also use domestically made bulk drugs, although they are mostly more expensive and less adopted, he said.
The administration has compiled an inventory of all US-made pharmaceutical products and sent a notice to their permit license holders to fully understand the medicine supply chain situation and properly boost domestic medicine stocks, he said.
It would also check stocks of primary medicines, such as anti-cancer drugs, orphan drugs and biologics to promptly initiate an investigation and evaluation whenever there is a potential shortage, he said.
The FDA would ask manufacturers of substitute medicines to increase production, or launch a drug import or manufacturing project, if necessary, he said.
Pharmaceutical companies can propose price adjustments to stabilize the market if changes in the global supply chain cause a surge in drug production costs, he said.
The ministry would continue to promote the application of generic drugs and biosimilars — biologics with similar structure and functions of a reference biologic made by another company — to bolster domestically made new medicines, Wang added.
A strong continental cold air mass is to bring pollutants to Taiwan from tomorrow, the Ministry of Environment said today, as it issued an “orange” air quality alert for most of the country. All of Taiwan except for Hualien and Taitung counties is to be under an “orange” air quality alert tomorrow, indicating air quality that is unhealthy for sensitive groups. In China, areas from Shandong to Shanghai have been enveloped in haze since Saturday, the ministry said in a news release. Yesterday, hourly concentrations of PM2.5 in these areas ranged from 65 to 160 micrograms per cubic meter (mg/m³), and pollutants were
Taiwan’s armed forces have established response protocols for a wide range of sudden contingencies, including the “Wan Chun Plan” to protect the head of state, the Ministry of Defense (MND) said today. After US President Donald Trump on Saturday launched a series of airstrikes in Venezuela and kidnapped Venezuelan President Nicolas Maduro, concerns have been raised as to whether China would launch a similar “decapitation strike” on Taiwan. The armed forces regularly coordinate with relevant agencies and practice drills to ensure preparedness for a wide range of scenarios, Vice Minister of National Defense Hsu Szu-chien (徐斯儉) told reporters before a
EVA Airways on Saturday said that it had suspended a pilot and opened an investigation after he allegedly lost his temper and punched the first officer several times as their plane was taxiing before takeoff at Los Angeles International Airport. According to a report published on Thursday by The Reporter, the incident occurred after the flight’s Malaysian first officer tried to warn the Taiwanese pilot, surnamed Wen (文), that he was taxiing faster than the speed limit of 30 knots (55.6kph). After alerting the pilot several times without response, the first officer manually applied the brakes in accordance with standard operating
NOT AN OPENING: Trump’s violation of international law does not affect China’s consideration in attacking Taiwan; Beijing lacks capability, not precedent, an official said Taiwanese officials see the US’ capture of the president of Venezuela as a powerful deterrent to Beijing’s aggression and a timely reminder of the US’ ability to defeat militaries equipped with Chinese-made weapons. The strikes that toppled Venezuelan President Nicolas Maduro signaled to authoritarian leaders, including Chinese President Xi Jinping (習近平), US President Donald Trump’s willingness to use military might for international affairs core to US interests, one senior official in Taipei’s security circle said. That reassured Taiwan, the person said. Taipei has also dismissed the idea that Trump’s apparent violation of international law could embolden Beijing, said the official, who was not
RSS